Search research articles
Contact Us
Filters
Showing results (121-130 of 151) with videos related to
Page
of 16
Sort By:
Vaccines
|
August 6, 2021
Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Carlos Meza-López, et al.
Clinical Chemistry and Laboratory Medicine
|
July 5, 2017
Handling the altered test results of hemolyzed samples. Recommendations of the Quality, Management, Safety and Evidence Committee (CCGSE) of the Spanish Association of Medical Biopathology and Laboratory Medicine (AEBM-ML)
Daniel Pineda-Tenor, Enrique Prada de Medio, Pedro María Belinchón Torres, et al.
Immunology Letters
|
October 24, 2022
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Andrea Carolina Machado-Sulbarán, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 23, 2020
Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study
Carlo Greco, Oriol Pares, Nuno Pimentel, et al.
The American Journal of Tropical Medicine and Hygiene
|
May 28, 2015
Prospective cohort study with active surveillance for fever in four dengue endemic countries in Latin America
Gustavo Dayan, Jose L Arredondo, Gabriel Carrasquilla, et al.
The Lancet. HIV
|
April 3, 2016
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
Joel E Gallant, Eric S Daar, François Raffi, et al.
Life (Basel, Switzerland)
|
September 28, 2024
Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population
José Alvaro Lomelí-Nieto, José Francisco Muñoz-Valle, José Eduardo Navarro-Zarza, et al.
Journal of Clinical Medicine
|
June 26, 2026
Tracheostomy and Ventilator-Associated Pneumonia in Mechanically Ventilated ICU Patients: A Retrospective Matched Cohort Study
Marie Nicoline Ordaz-Kücks, Iván Alejandro Arteaga-Martínez, Hugo Alfredo Funes-González, et al.
Journal of Diabetes and Its Complications
|
January 20, 2023
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, Javed Butler, George L Bakris, et al.
Therapeutic Advances in Hematology
|
May 8, 2026
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study
Davide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 151) with videos related to
Sort By:
Page
of 16
Vaccines
|
August 6, 2021
Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Carlos Meza-López, et al.
Clinical Chemistry and Laboratory Medicine
|
July 5, 2017
Handling the altered test results of hemolyzed samples. Recommendations of the Quality, Management, Safety and Evidence Committee (CCGSE) of the Spanish Association of Medical Biopathology and Laboratory Medicine (AEBM-ML)
Daniel Pineda-Tenor, Enrique Prada de Medio, Pedro María Belinchón Torres, et al.
Immunology Letters
|
October 24, 2022
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Andrea Carolina Machado-Sulbarán, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 23, 2020
Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study
Carlo Greco, Oriol Pares, Nuno Pimentel, et al.
The American Journal of Tropical Medicine and Hygiene
|
May 28, 2015
Prospective cohort study with active surveillance for fever in four dengue endemic countries in Latin America
Gustavo Dayan, Jose L Arredondo, Gabriel Carrasquilla, et al.
The Lancet. HIV
|
April 3, 2016
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
Joel E Gallant, Eric S Daar, François Raffi, et al.
Life (Basel, Switzerland)
|
September 28, 2024
Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population
José Alvaro Lomelí-Nieto, José Francisco Muñoz-Valle, José Eduardo Navarro-Zarza, et al.
Journal of Clinical Medicine
|
June 26, 2026
Tracheostomy and Ventilator-Associated Pneumonia in Mechanically Ventilated ICU Patients: A Retrospective Matched Cohort Study
Marie Nicoline Ordaz-Kücks, Iván Alejandro Arteaga-Martínez, Hugo Alfredo Funes-González, et al.
Journal of Diabetes and Its Complications
|
January 20, 2023
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, Javed Butler, George L Bakris, et al.
Therapeutic Advances in Hematology
|
May 8, 2026
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study
Davide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Page
of 16